TITLE:
Alternate Day Buprenorphine Administration, Phase XII - 17

CONDITION:
Opioid-Related Disorders

INTERVENTION:
Buprenorphine

SUMMARY:

      The purpose of this study is to determine if six times daily buprenorphine dose is effective
      in achieving 120 hour buprenorphine dosing.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Please contact site for information.
      
